MOR.DE - Morphosys AG

XETRA - XETRA Delayed Price. Currency in EUR
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue50,000106,00064,00078,000
Cost of Revenue----
Gross Profit50,000106,00064,00078,000
Operating Expenses
Research Development----
Selling General and Administrative----
Non Recurring----
Total Operating Expenses100,00090,00066,00066,000
Operating Income or Loss-50,00016,000-2,00012,000
Income from Continuing Operations
Total Other Income/Expenses Net----
Earnings Before Interest and Taxes-50,00016,000-2,00012,000
Interest Expense----
Income Before Tax----
Income Tax Expense1,0006,000-1,0003,000
Minority Interest----
Net Income From Continuing Ops----
Non-recurring Events
Discontinued Operations---6,000
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-60,00015,000-3,00013,000
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares----